WHO recommends two more drugs for Covid-19 patients

These are the active ingredient baricitinib, which was developed to treat rheumatoid arthritis, and sotrovimab, a monoclonal antibody developed specifically for Covid-19 patients.

The new recommendation is based on seven studies with more than 4000 patients. The WHO experts reported this in the specialist magazine “The BMJ”.

Seriously ill Covid 19 patients would have better chances of survival with baricitinib and the need for artificial ventilation would be reduced, according to the new policy. No side effects were observed. The drug is to be administered in combination with corticosteroids.

Patients with less severe disease but at high risk of hospitalization may benefit from the use of the monoclonal antibody sotrovimab, writes the WHO. The product with the brand name Xevudy is also approved in the EU. The WHO has already advocated the use of another antibody cocktail, casirivimab/imdevimab.

Swiss treaties

The Federal Office of Public Health (BAG ) has signed contracts for the reservation of drugs against Covid-19 with the companies GlaxoSmithKline and Roche Pharma, as announced in December. Sotrovimab and the combination Casirivima/Imdevimab are affected.

According to the BAG, Sotrovimab and Casirivimab/Imdevimab have been available in Switzerland since September 30 and May 13, 2021 respectively, on the recommendation of the task force.

Sotrovimab is not yet approved, but can be used to treat Covid-19 patients during the ongoing approval process due to the Covid-19 Ordinance 3 and a submitted approval application. Casirivimab/Imdevimab received approval in December.

However, the WHO advises against the use of two other drugs, ruxolitinib and tofacitinib. Small studies have so far shown no benefit, and serious side effects could potentially develop with tofacitinib.

Note: This article has been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Loss of IDR 4 Trillion in 2020/21, Inter Milan Becomes the Most 'Boncos' Club in Serie A History thumbnail

Loss of IDR 4 Trillion in 2020/21, Inter Milan Becomes the Most 'Boncos' Club in Serie A History

Presiden Inter Milan Steven Zhang. (c) AP Photo Bola.net - Krisis finansial yang dialami Inter Milan semakin terkuak. Juara bertahan Serie A tersebut mengumumkan kerugian sebesar 245 juta euro (setara Rp4 Triliun) di musim 2020/21. Kesulitan ekonomi yang dialami Nerazzurri sudah tercium sejak awal tahun 2021 ini. Beberapa laporan menyatakan kalau Suning Group diketahui ingin…
Read More
Report: Double fracture for Juventus midfielder McKennie thumbnail

Report: Double fracture for Juventus midfielder McKennie

Please enable cookies. You are unable to access football-italia.net Why have I been blocked? This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command…
Read More
Celtic-Rangers da brividi, le quote sono equilibrate thumbnail

Celtic-Rangers da brividi, le quote sono equilibrate

La partita più attesa del massimo campionato scozzese va in scena mercoledì sera al Celtic Park di Glasgow dove il Celtic secondo in classifica proverà a sorpassare i Rangers, attualmente primi con 56 punti contro i 54 dei biancoverdi. Ecco analisi e pronostico dell'Old Firm. Celtic-Rangers da brividi, fai il tuo pronostico! Missione rivincita per…
Read More
Sean O’Malley: ‘I’m the best striker in the world’ thumbnail

Sean O’Malley: ‘I’m the best striker in the world’

Sean O’Malley, the top contender in the UFC bantamweight division, catapulted up the rankings following his UFC 280 split decision win over former champion Petr Yan. Yan is considered one of the best strikers in the division, and O’Malley was able to hurt “No Mercy” a few times during their fight. Many people were surprised
Read More
Index Of News
Total
0
Share